HCAT Quote, Financials, Valuation and Earnings

AMN Healthcare Services, Inc. has a net margin of -29.13% compared to Health Catalyst, Inc.'s net margin of -1.03%. Health Catalyst, Inc.'s return on equity of -30.29% beat AMN Healthcare Services, Inc.'s return on equity of -14.43%.

Health Catalyst, Inc. has a consensus price target of $3.88, signalling upside risk potential of 130.66%. On the other hand AMN Healthcare Services, Inc. has an analysts' consensus of $22.21 which suggests that it could grow by 8.89%. Given that Health Catalyst, Inc. has higher upside potential than AMN Healthcare Services, Inc., analysts believe Health Catalyst, Inc. is more attractive than AMN Healthcare Services, Inc..

Health Catalyst, Inc. has a beta of 1.764, which suggesting that the stock is 76.444% more volatile than S&P 500. In comparison AMN Healthcare Services, Inc. has a beta of 0.234, suggesting its less volatile than the S&P 500 by 76.564%.

Health Catalyst, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AMN Healthcare Services, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Health Catalyst, Inc. pays -- of its earnings as a dividend. AMN Healthcare Services, Inc. pays out -- of its earnings as a dividend.

Health Catalyst, Inc. quarterly revenues are $76.3M, which are smaller than AMN Healthcare Services, Inc. quarterly revenues of $748.2M. Health Catalyst, Inc.'s net income of -$22.2M is lower than AMN Healthcare Services, Inc.'s net income of -$7.7M. Notably, Health Catalyst, Inc.'s price-to-earnings ratio is -- while AMN Healthcare Services, Inc.'s PE ratio is 18.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst, Inc. is 0.36x versus 0.29x for AMN Healthcare Services, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Chemed Corp. has a net margin of -29.13% compared to Health Catalyst, Inc.'s net margin of 12.01%. Health Catalyst, Inc.'s return on equity of -30.29% beat Chemed Corp.'s return on equity of 23.87%.

Health Catalyst, Inc. has a consensus price target of $3.88, signalling upside risk potential of 130.66%. On the other hand Chemed Corp. has an analysts' consensus of $443.00 which suggests that it could grow by 5.13%. Given that Health Catalyst, Inc. has higher upside potential than Chemed Corp., analysts believe Health Catalyst, Inc. is more attractive than Chemed Corp..

Health Catalyst, Inc. has a beta of 1.764, which suggesting that the stock is 76.444% more volatile than S&P 500. In comparison Chemed Corp. has a beta of 0.465, suggesting its less volatile than the S&P 500 by 53.494%.

Health Catalyst, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Chemed Corp. offers a yield of 0.55% to investors and pays a quarterly dividend of $0.60 per share. Health Catalyst, Inc. pays -- of its earnings as a dividend. Chemed Corp. pays out 11.99% of its earnings as a dividend. Chemed Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Health Catalyst, Inc. quarterly revenues are $76.3M, which are smaller than Chemed Corp. quarterly revenues of $639.3M. Health Catalyst, Inc.'s net income of -$22.2M is lower than Chemed Corp.'s net income of $76.8M. Notably, Health Catalyst, Inc.'s price-to-earnings ratio is -- while Chemed Corp.'s PE ratio is 22.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst, Inc. is 0.36x versus 2.41x for Chemed Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Humana, Inc. has a net margin of -29.13% compared to Health Catalyst, Inc.'s net margin of -2.39%. Health Catalyst, Inc.'s return on equity of -30.29% beat Humana, Inc.'s return on equity of 6.77%.

Health Catalyst, Inc. has a consensus price target of $3.88, signalling upside risk potential of 130.66%. On the other hand Humana, Inc. has an analysts' consensus of $223.88 which suggests that it could grow by 19.54%. Given that Health Catalyst, Inc. has higher upside potential than Humana, Inc., analysts believe Health Catalyst, Inc. is more attractive than Humana, Inc..

Health Catalyst, Inc. has a beta of 1.764, which suggesting that the stock is 76.444% more volatile than S&P 500. In comparison Humana, Inc. has a beta of 0.440, suggesting its less volatile than the S&P 500 by 55.989%.

Health Catalyst, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humana, Inc. offers a yield of 1.89% to investors and pays a quarterly dividend of $0.89 per share. Health Catalyst, Inc. pays -- of its earnings as a dividend. Humana, Inc. pays out 36% of its earnings as a dividend. Humana, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Health Catalyst, Inc. quarterly revenues are $76.3M, which are smaller than Humana, Inc. quarterly revenues of $32.5B. Health Catalyst, Inc.'s net income of -$22.2M is higher than Humana, Inc.'s net income of -$776M. Notably, Health Catalyst, Inc.'s price-to-earnings ratio is -- while Humana, Inc.'s PE ratio is 19.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst, Inc. is 0.36x versus 0.17x for Humana, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Regional Health Properties, Inc. has a net margin of -29.13% compared to Health Catalyst, Inc.'s net margin of 22.34%. Health Catalyst, Inc.'s return on equity of -30.29% beat Regional Health Properties, Inc.'s return on equity of --.

Health Catalyst, Inc. has a consensus price target of $3.88, signalling upside risk potential of 130.66%. On the other hand Regional Health Properties, Inc. has an analysts' consensus of -- which suggests that it could grow by 400%. Given that Regional Health Properties, Inc. has higher upside potential than Health Catalyst, Inc., analysts believe Regional Health Properties, Inc. is more attractive than Health Catalyst, Inc..

Health Catalyst, Inc. has a beta of 1.764, which suggesting that the stock is 76.444% more volatile than S&P 500. In comparison Regional Health Properties, Inc. has a beta of 1.054, suggesting its more volatile than the S&P 500 by 5.399%.

Health Catalyst, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Regional Health Properties, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Health Catalyst, Inc. pays -- of its earnings as a dividend. Regional Health Properties, Inc. pays out -- of its earnings as a dividend.

Health Catalyst, Inc. quarterly revenues are $76.3M, which are larger than Regional Health Properties, Inc. quarterly revenues of $15.1M. Health Catalyst, Inc.'s net income of -$22.2M is lower than Regional Health Properties, Inc.'s net income of $3.4M. Notably, Health Catalyst, Inc.'s price-to-earnings ratio is -- while Regional Health Properties, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst, Inc. is 0.36x versus 0.08x for Regional Health Properties, Inc.. Usually stocks with elevated PS ratios are considered overvalued.